Investigating potential mechanisms underlying FVIII inhibition in acquired hemophilia A associated with mRNA COVID-19 vaccines

被引:15
作者
Hirsiger, Julia R. [1 ]
Martinez, Maria [2 ]
Tsakiris, Dimitrios A. [2 ]
Cittone, Micol G. [3 ]
Graf, Lukas [4 ]
Oldenburg, Johannes [5 ]
Pezeshkpoor, Behnaz [5 ]
Recher, Mike [6 ,7 ]
Mueller, Jens [5 ]
Gerber, Bernhard [3 ,8 ]
Berger, Christoph T. [1 ,7 ,9 ]
机构
[1] Univ Basel, Dept Biomed, Translat Immunol, Basel, Switzerland
[2] Univ Hosp Basel, Div Hematol, Basel, Switzerland
[3] EOC, Oncol Inst Southern Switzerland, Clin Hematol, Bellinzona, Switzerland
[4] Ctr Lab Med, Hemophilia & Hemostasis Ctr, St Gallen, Switzerland
[5] Univ Bonn, Univ Hosp Bonn, Inst Expt Hematol & Transfus Med, Fac Med, Bonn, Germany
[6] Univ Basel, Dept Biomed, Immunodeficiency, Basel, Switzerland
[7] Univ Hosp Basel, Univ Ctr Immunol, Petersgraben 4, CH-4031 Basel, Switzerland
[8] Univ Zurich, Zurich, Switzerland
[9] Univ Hosp Basel, Med Outpatient Clin, Immunizat Clin, Basel, Switzerland
关键词
FACTOR-VIII; ANTIBODIES;
D O I
10.1111/jth.15665
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1015 / 1018
页数:4
相关论文
共 14 条
[1]   NATURAL ANTIBODIES TO FACTOR-VIII (ANTI-HEMOPHILIC FACTOR) IN HEALTHY-INDIVIDUALS [J].
ALGIMAN, M ;
DIETRICH, G ;
NYDEGGER, UE ;
BOIELDIEU, D ;
SULTAN, Y ;
KAZATCHKINE, MD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (09) :3795-3799
[2]   ChAdOx1 interacts with CAR and PF4 with implications for thrombosis with thrombocytopenia syndrome [J].
Baker, Alexander T. ;
Boyd, Ryan J. ;
Sarkar, Daipayan ;
Teijeira-Crespo, Alicia ;
Chan, Chun Kit ;
Bates, Emily ;
Waraich, Kasim ;
Vant, John ;
Wilson, Eric ;
Truong, Chloe D. ;
Lipka-Lloyd, Magdalena ;
Fromme, Petra ;
Vermaas, Josh ;
Williams, Dewight ;
Machiesky, LeeAnn ;
Heurich, Meike ;
Nagalo, Bolni M. ;
Coughlan, Lynda ;
Umlauf, Scott ;
Chiu, Po-Lin ;
Rizkallah, Pierre J. ;
Cohen, Taylor S. ;
Parker, Alan L. ;
Singharoy, Abhishek ;
Borad, Mitesh J. .
SCIENCE ADVANCES, 2021, 7 (49)
[3]   The statistical risk of diagnosing coincidental acquired hemophilia A following anti-SARS-CoV-2 vaccination [J].
Cittone, Micol G. ;
Battegay, Raphael ;
Condoluci, Adalgisa ;
Terzi di Bergamo, Lodovico ;
Fernandes, Eliana ;
Galfetti, Elena ;
Noseda, Roberta ;
Leuppi-Taegtmeyer, Anne ;
Drexler, Beatrice ;
Ceschi, Alessandro ;
Tsakiris, Dimitrios A. ;
Berger, Christoph T. ;
Favre, Genevieve ;
Martin, Thomas ;
Korte, Wolfgang ;
Graf, Lukas ;
Martinez, Maria ;
Gerber, Bernhard .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2021, 19 (09) :2360-2362
[4]  
Greinacher Andreas, 2021, Blood, V138, P1269, DOI 10.1182/blood.2021012938
[5]  
Meunier Sylvain, 2017, Blood Adv, V1, P1842, DOI 10.1182/bloodadvances.2017008706
[6]   Comparison of clot-based, chromogenic and fluorescence assays for measurement of factor VIII inhibitors in the US Hemophilia Inhibitor Research Study [J].
Miller, C. H. ;
Rice, A. S. ;
Boylan, B. ;
Shapiro, A. D. ;
Lentz, S. R. ;
Wicklund, B. M. ;
Kelly, F. M. ;
Soucie, J. M. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 (07) :1300-1309
[7]   Acquired factor VIII haemophilia following influenza vaccination [J].
Moulis, Guillaume ;
Pugnet, Gregory ;
Bagheri, Haleh ;
Courtellemont, Claire ;
Huart, Antoine ;
Chauveau, Dominique ;
Pourrat, Jacques ;
Montastruc, Jean-Louis .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 66 (10) :1069-+
[8]   Crystal structure of human factor VIII: Implications for the formation of the factor IXa-factor VIIIa complex [J].
Ngo, Jacky Chi Ki ;
Huang, Mingdong ;
Roth, David A. ;
Furie, Barbara C. ;
Furie, Bruce .
STRUCTURE, 2008, 16 (04) :597-606
[9]   Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis [J].
Pavord, Sue ;
Scully, Marie ;
Hunt, Beverley J. ;
Lester, William ;
Bagot, Catherine ;
Craven, Brian ;
Rampotas, Alex ;
Ambler, Gareth ;
Makris, Mike .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (18) :1680-1689
[10]   A case of acquired haemophilia following H1N1 vaccination [J].
Pirrotta, M. T. ;
Bernardeschi, P. ;
Fiorentini, G. .
HAEMOPHILIA, 2011, 17 (05) :815-815